(Finance) – Pharmacosma company listed since March 2022 on Euronext Growth Milan and active in the Health, Pharma & Beauty sector, has registered revenues equal to 17.7 million euros in the first quarter of 2022, an increase of 20% compared to the first quarter of 2021. The number of users on the pharmacosmo.it portal, exceeding 3.1 million units in the quarter and the number of orders increased significantly, reaching approximately 115 thousand, + 32% compared to the first quarter of 2021. The conversion rate, rising to 3.43% in Q1 2022 (2.69% in Q1 2021), thanks to competitive positioning, marketing strategy and customer journey. The value of the medium cart (AOV), which stands at over 96 euros.
“The data for the first quarter confirm the virtuous path that the company has experienced in recent years – commented theAD Fabio de Concilio – The data relating to the conversion rate (3.43%, + 28% YoY) testifies to the effectiveness of our strategy. This element, read together with a further increase in the average trolley (96 euros), represents excellence in the reference sector. Thanks to the IPO, the company will be able to accelerate its development plan through a growth strategy for internal and external lines“.
The Board of Directors approved the start of the buy-back and disposal program for own shares, in execution of the resolution in this regard by the shareholders’ meeting of the company last March 2, 2022. The duration of the program is between May 2, 2022 and September 2, 2023. The purchases will involve ordinary shares of Farmacosmo, with no par value , for a maximum total value of 450,000 euros. To date, the company does not hold any own shares in its portfolio. The program will be coordinated by MIT SIM.